| Literature DB >> 32820063 |
Fiachra Humphries1, Liraz Shmuel-Galia1, Natalia Ketelut-Carneiro1, Sheng Li2, Bingwei Wang3, Venkatesh V Nemmara4, Ruth Wilson1, Zhaozhao Jiang1, Farnaz Khalighinejad5, Khaja Muneeruddin6,7, Scott A Shaffer6,7, Ranjan Dutta8, Carolina Ionete5, Scott Pesiridis9, Shuo Yang2, Paul R Thompson7, Katherine A Fitzgerald10.
Abstract
Activated macrophages undergo a metabolic switch to aerobic glycolysis, accumulating Krebs' cycle intermediates that alter transcription of immune response genes. We extended these observations by defining fumarate as an inhibitor of pyroptotic cell death. We found that dimethyl fumarate (DMF) delivered to cells or endogenous fumarate reacts with gasdermin D (GSDMD) at critical cysteine residues to form S-(2-succinyl)-cysteine. GSDMD succination prevents its interaction with caspases, limiting its processing, oligomerization, and capacity to induce cell death. In mice, the administration of DMF protects against lipopolysaccharide shock and alleviates familial Mediterranean fever and experimental autoimmune encephalitis by targeting GSDMD. Collectively, these findings identify GSDMD as a target of fumarate and reveal a mechanism of action for fumarate-based therapeutics that include DMF, for the treatment of multiple sclerosis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32820063 PMCID: PMC8744141 DOI: 10.1126/science.abb9818
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728